(Q30781159)

26 June 2017

1 reference

title

Campylobacter and fluoroquinolones: a bias data set? (English)

1 reference

26 June 2017

1 reference

1 reference

1

Peter Silley

1 reference

26 June 2017

1 April 2003

1 reference

Environmental Microbiology

26 June 2017

1 reference

26 June 2017

5

1 reference

26 June 2017

4

1 reference

26 June 2017

219-230

1 reference

Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection

26 June 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Culture media for the isolation of campylobacters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Elimination of fecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate--a microbiological and pharmacokinetic study in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

CmeABC functions as a multidrug efflux system in Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Effects of rice seed surface sterilization with hypochlorite on inoculated Burkholderia vietnamiensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Changes in the carriage of Campylobacter strains by poultry carcasses during processing in abattoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Coinfection with Campylobacter species: an epidemiological problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

High-Level Quinolone Resistance in Clinical Isolates of Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Use of norfloxacin in the treatment of acute diarrheal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Polymerase chain reaction detection and speciation of Campylobacter upsaliensis and C. helveticus in human faeces and comparison with culture techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

Detection of campylobacter in gastroenteritis: comparison of direct PCR assay of faecal samples with selective culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1462-2920.2003.00425.X

10.1046/J.1462-2920.2003.00425.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

12662169